A Short-Term Comparison of Fluticasone Propionate/Salmeterol with Ipratropium Bromide/Albuterol for the Treatment of COPD

By Donohue James F.  

Treatments in Respiratory Medicine, Vol. 3, Iss. 3, 2004-01 ,pp. : 173-181

Adis International

Access to resources Recommend Favorite

Comparison of Patient-Reported Outcomes During Treatment With Adjustable- and Fixed-Dose Budesonide/Formoterol Pressurized Metered-Dose Inhaler Versus Fixed-Dose Fluticasone Propionate/Salmeterol Dry Powder Inhaler in Patients With Asthma

By O'Connor Richard D.   Patrick Donald L.   Parasuraman Bhash   Martin Paula   Goldman Mitchell  

Journal of Asthma, Vol. 47, Iss. 2, 2010-03 ,pp. : 217-223

Informa Healthcare

Access to resources Recommend Favorite

Patient-Reported Outcomes among Omalizumab and Salmeterol/Fluticasone Combination Therapy Patients

By Miller Dave   Tom Gladys   Rasouliyan Lawrence   Chipps Bradley  

Journal of Asthma, Vol. 46, Iss. 2, 2009-03 ,pp. : 179-185

Informa Healthcare

Access to resources Recommend Favorite

Improved Ability to Perform Strenuous Activities After Treatment with Fluticasone Propionate/Salmeterol Combination in Patients with Persistent Asthma

By Nathan Robert A.   Dorinsky Paul   Carranza Rosenzweig Jacqueline R.   Shah Tushar   Edin Heather   Prillaman Barbara  

Journal of Asthma, Vol. 40, Iss. 7, 2003-01 ,pp. : 815-822

Informa Healthcare

Access to resources Recommend Favorite

Deterioration in Asthma Control When Subjects Receiving Fluticasone Propionate/Salmeterol 100/50 mcg Diskus are “Stepped-Down”

By Koenig Steven   Ostrom Nancy   Pearlman David   Waitkus-Edwards Kelli   Yancey Steven   Prillaman Barbara   Dorinsky Paul  

Journal of Asthma, Vol. 45, Iss. 8, 2008-10 ,pp. : 681-687

Informa Healthcare

Access to resources Recommend Favorite